Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit-Reference-Cited by-同舟云学术

Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit

Published:2017-12-21 Issue:3 Volume:53 Page:315-325
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ragon Brittany Knick,Mehta Rohtesh S.,Gulbis Alison M.,Saliba Rima M.,Chen Julianne,Rondon Gabriela,Popat Uday R.,Nieto Yago,Oran Betul,Olson Amanda L.^ORCID,Patel Krina,Hosing Chitra M.,Qazilbash Muzaffar H.^ORCID,Shah Nina,Kebriaei Partow,Shpall Elizabeth J.,Champlin Richard E.,Alousi Amin M.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-017-0034-z.pdf

Reference64 articles.

1. Mielcarek M, Storer BE, Boeckh M, Carpenter PA, McDonald GB, Deeg HJ, et al. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. Blood. 2009;113:2888–94. https://doi.org/10.1182/blood-2008-07-168401.

2. MacMillan ML, Weisdorf DJ, Wagner JE, DeFor TE, Burns LJ, Ramsay NK, et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant. 2002;8:387–94.

3. Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N, et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation. 1991;51:1197–203.

4. Hings IM, Severson R, Filipovich AH, Blazar BR, Kersey JH, Ramsay NK, et al. Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation. Transplantation. 1994;58:437–42.

5. Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB, et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood. 1991;77: 1821–8.